Subretinal organization in stage 5 retinopathy of prematurity

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 241, Issue 4, 2003, Pages 263-268

  Steidl, Scott M ^a   Hirose, Tatsuo ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHOROID DISEASE; CONTROLLED STUDY; CRYOTHERAPY; DATA ANALYSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; HUMAN; LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; MEDICAL RECORD; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETINA DETACHMENT; RETROLENTAL FIBROPLASIA; RETROSPECTIVE STUDY; SURGICAL TECHNIQUE; VITRECTOMY;

EID: 0038338544     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-003-0632-x     Document Type: Article

References (16)

1. Anonymous (1983) The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology 90:121-125
2. Campochiaro PA, Jerdan JA, Glaser BM (1984) Serum contains chemoattractants for human retinal pigment epithelial cells. Arch Ophthalmol 102:1830-1833
3. Campochiaro PA, Kaden IH, Vidaurri-Leal J, Glaser BM (1985) Cryotherapy enhances intravitreal dispersion of viable retinal pigment epithelial cells. Arch Ophthalmol 103:434-436
4. Cassidy L Barry P, Shaw C, Duffy J, Kennedy S (1998) Platelet derived growth factor and fibroblast growth factor basic levels in the vitreous of patients with vitreoretinal disorders. Br J Ophthalmol 82:181-185
5. Chen YS, Hackett SF, Schoenfeld CL, Vinores MA, Campochiaro PA (1997) Localization of vascular endothelial growth factor to vascular and avascular epiretinal membranes. Br J Ophthalmol 81:919-926
6. Connor T Jr, Roberts AB, Sporn MB, Davis J, Glaser BM (1988) RPE cells synthesize and release transforming growth factor-beta, a modulator of endothelial cell growth and wound healing. Invest Ophthalmol Vis Sci 29:307
7. Cryotherapy for Retinopathy of Prematurity Cooperative Group (1996) Cryotherapy for retinopathy of prematurity: Snellen visual acuity and structural outcome at 5 1/2 years after randomization. Arch Ophthalmol 114:417-424
8. Hirose T, Schepens CL, Katsumi O, Mehta M (1992) Open-sky vitrectomy in severe retinal detachment caused by advanced retinopathy of prematurity. In: Flynn JT, Tasman W (eds) Retinopathy of prematurity. Springer, New York Berlin Heidelberg, pp 95-114
9. Hirose T, Katsumi O, Mehta MC, Schepens CL(1993) Vision in stage 5 retinopathy of prematurity after retinal reattachment by open-sky vitrectomy. Arch Ophthalmol 111:345-349
10. Holtkamp GM, De Vos AF, Peek R, Kijlsta A (1999) Analysis of the secretion pattern of monocyte chemotactic protein-1 (MCP-1) and transforming growth factor-beta 2 (TGF-beta2) by human retinal pigment epithelial cells. Clin Exp Immunol 118:35-40
11. Laqua H, Machemer R (1975) Glial cell proliferation in retinal detachment (massive periretinal proliferation). Am J Ophthalmol 80:602-618
12. Machemer R, Laqua H (1975) Pigment epithelium proliferation in retinal detachment (massive periretinal proliferation). Am J Ophthalmol 80:1-23
13. Sporn MB, Roberts AB, Wakefield LM, Crombrugghe B (1987) Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol 105:1039-1045
14. Vidaurri-Leal J, Hohman R, Glaser BM (1984) Effect of vitreous on morphologic characteristics of retinal pigment epithelial cells: a new approach to the study of proliferative vitreoretinopathy Arch Ophthalmol 102:1220-1223
15. Vidaurri-Leal J, Glaser BM (1984) Effect of fibrin on morphologic characteristics of retinal pigment epithelial cells. Arch Ophthalmol 102:1376-1379
16. Yamada KM (1983) Cell surface interactions with extracellular materials. Annu Rev Biochem 52:761-799